Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Vertex Pharmaceuticals Incorporated VRTX

Healthcare  —  Biotechnology
526.19 3.81 0.73% as of 25 Sep
Market cap
$132.3B
P/E
30.4×
S&P 500 Member Revenue Champion (10y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Vertex Pharmaceuticals Incorporated (VRTX) Book value per share

Vertex Pharmaceuticals Incorporated's book value per share at the end of fiscal 2025 was 73.0×, up 14.7% from 63.6× in fiscal 2024. At the end of the quarter to 30 June 2026 it was 79.8×. Over the past ten years it has ranged from 4.5× (fiscal 2015) to 73.0× (fiscal 2025) — the current reading is the highest in ten years. Vertex Pharmaceuticals Incorporated ranks 9th of 614 Biotechnology companies by book value per share.

Book value per share, annual

Annual

Period Book value per share Change
FY2025 73.0× 14.73%
FY2024 63.6× (6.73%)
FY2023 68.2× 25.58%
FY2022 54.3× 38.61%
FY2021 39.2× 17.22%
FY2020 33.4× 41.05%
FY2019 23.7× 35.92%
FY2018 17.4× 112.53%
FY2017 8.2× 50.06%
FY2016 5.5× 20.68%

Quarterly

Period Book value per share Change
Jun 2026 79.8× 4.74%
Mar 2026 76.2× 4.38%
Dec 2025 73.0× 7.74%
Sep 2025 67.8× 1.27%
42 more quarters

Against its own ten years

Low 4.5× High 73.0×
Ten-year median 33.4×
Current reading's percentile 100

Book value per share against peers

Company Book value per share
REGN Regeneron Pharmaceuticals, Inc. compare 308×
ARGX argenex SE compare 135×
VRTX Vertex Pharmaceuticals Incorporated 79.8×
ONC BeOne Medicines Ltd. - Sponsored ADR compare 46.4×
RPRX Royalty Pharma PLC compare 22.0×
MRNA Moderna, Inc. compare 17.0×
RVMD Revolution Medicines, Inc. compare 12.4×
ALNY Alnylam Pharmaceuticals, Inc. compare 10.1×
INSM Insmed, Inc. compare 3.5×

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

More on VRTX